Early results from a double-blind, randomized phase IIB trial of difluoromethylorthine plus sulindac for colon cancer prevention.

被引：0
|
作者：
Meyskens, FL
Pelot, D
MacLaren, CE
Lagerberg, W
Li, KT
Carpenter, P
Gerner, E
Goldschmid, S
Kidao, J
Ahnen, D
Lawson, MJ
McCracken, J
机构：
[1] Chao Family Comprehens Canc Ctr, Orange, CA USA
[2] Univ Calif Irvine, Irvine, CA USA
[3] Arizona Canc Ctr, Tucson, AZ USA
[4] Long Beach VA Med Ctr, Long Beach, CA USA
[5] Univ Colorado, Sch Med, Denver, CO USA
[6] Kaiser Permanente, Sacramento, CA USA
[7] Loma Linda Univ, Loma Linda, CA 92350 USA
[8] Pettis VA Med Ctr, Loma Linda, CA USA
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2004年 / 13卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1904S / 1904S
页数：1
相关论文
共 50 条
  • [41] TREATMENT OF ALCOHOLIC HEPATITIS WITH COLCHICINE - RESULTS OF A RANDOMIZED DOUBLE-BLIND TRIAL
    TRINCHET, JC
    BEAUGRAND, M
    CALLARD, P
    HARTMANN, DJ
    GOTHEIL, C
    NUSGENS, BV
    LAPIERE, CM
    FERRIER, JP
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1989, 13 (6-7): : 551 - 555
  • [42] PYLOROPLASTY VERSUS GASTROJEJUNOSTOMY - RESULTS OF A DOUBLE-BLIND, RANDOMIZED, CONTROLLED TRIAL
    KENNEDY, T
    JOHNSTON, GW
    LOVE, AHG
    CONNELL, AM
    SPENCER, EFA
    BRITISH JOURNAL OF SURGERY, 1973, 60 (12) : 949 - 953
  • [43] Treatment of lymphocutaneous sporotrichosis with terbinafine: Results of randomized double-blind trial
    Pappas, PG
    Bustamante, B
    Nolasco, D
    Restrepo, A
    Toban, A
    Foss, NT
    Dietze, R
    Fothergill, A
    Perez, A
    Felser, J
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1199 - 1199
  • [44] Levetiracetam for partial seizures - Results of a double-blind, randomized clinical trial
    Cereghino, JJ
    Biton, V
    Abou-Khalil, B
    Dreifuss, F
    Gauer, LJ
    Leppik, I
    NEUROLOGY, 2000, 55 (02) : 236 - 242
  • [45] First-line serplulimab in metastatic colorectal cancer: Phase 2 results of a randomized, double-blind, phase 2/3 trial
    Wang, Zi-Xian
    Peng, Junjie
    Liang, Xinjun
    Cheng, Ying
    Deng, Yanhong
    Chen, Kehe
    Zhang, Mingjun
    Zhang, Jingdong
    Wang, Wei
    Cao, Bangwei
    Jin, Yongdong
    Sun, Meili
    Lin, Yuan
    Luo, Suxia
    Li, Zhen
    Yang, Liu
    Ke, Ying
    Yu, Haoyu
    Li, Jing
    Wang, Qingyu
    Zhu, Jun
    Wang, Feng
    Xu, Rui-Hua
    MED, 2024, 5 (09):
  • [46] Risperidone plus celecoxib in children with autistic disorder: a double-blind, randomized trial
    Akhondzadeh, S.
    Asadabadi, M.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 73 (06) : 983 - 984
  • [47] EFFICACY AND SAFETY OF COMBINED CPP-1X/SULINDAC VS CPP-1X OR SULINDAC ALONE IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS: RESULTS FROM A DOUBLE-BLIND, RANDOMIZED PHASE III TRIAL
    Burke, Carol A.
    Samadder, N. Jewel
    Dekker, Evelien
    Lim, Ramona M.
    Balaguer, Francesc
    Gallinger, Steven
    Huneburg, Robert
    Strassburg, Christian P.
    Lynch, Patrick M.
    Cohen, Alfred
    Gupta, Samir
    Stoffel, Elena M.
    GASTROENTEROLOGY, 2019, 156 (06) : S79 - S79
  • [48] A Randomized, Double-Blind Trial of Saxagliptin Add-on to Dapagliflozin plus Metformin
    Matthaei, Stephan
    Catrinoiu, Doina
    Celinski, Aleksander
    Ekholm, Ella
    Cook, William
    Hirshberg, Boaz
    Iqbal, Nayyar
    Hansen, Lars
    DIABETES, 2015, 64 : A27 - A28
  • [49] FAIRLANE, a double-blind placebo-controlled randomized phase II trial of neoadjuvant ipatasertib plus paclitaxel for early triple-negative breast cancer
    Oliveira, M.
    Saura, C.
    Nuciforo, P.
    Calvo, I
    Andersen, J.
    Passos-Coelho, J. L.
    Gil Gil, M.
    Bermejo, B.
    Patt, D. A.
    Ciruelos, E.
    de la Pena, L.
    Xu, N.
    Wongchenko, M.
    Shi, Z.
    Singel, S. M.
    Isakoff, S. J.
    ANNALS OF ONCOLOGY, 2019, 30 (08) : 1289 - 1297
  • [50] DOUBLE-BLIND RANDOMIZED TRIAL OF NICOTINAMIDE ON EARLY-ONSET DIABETES
    LEWIS, CM
    CANAFAX, DM
    SPRAFKA, JM
    BARBOSA, JJ
    DIABETES CARE, 1992, 15 (01) : 121 - 123
12345